Celaidtx
3 known investors
Find your way into Celaidtx
Sign up to see every warm intro you have to Celaidtx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Celaidtx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Celaid Therapeutics develops hematopoietic stem cell expansion technology, including a method to replace albumin with polyvinyl alcohol and to expand human hematopoietic stem cells ex vivo in large quantities. The company applies this technology to stem cell transplantation and gene therapy for blood cancers such as leukemia and other blood and genetic diseases.
Founders & leadership




Investors · 3
How we know: Kobe University Capital's portfolio page · Not right? Tell us
How we know: OSAKA University Venture Capital's portfolio page · Not right? Tell us
How we know: UTEC's portfolio page · Not right? Tell us
Related companies · 6
Companies working in the same space as Celaidtx.
Frequently asked questions
- What does Celaidtx do?
- Celaid Therapeutics develops hematopoietic stem cell expansion technology, including a method to replace albumin with polyvinyl alcohol and to expand human hematopoietic stem cells ex vivo in large quantities. The company applies this technology to stem cell transplantation and gene therapy for blood cancers such as leukemia and other blood and genetic diseases.
- Who founded Celaidtx?
- Celaidtx was founded by Nobuyuki Arakawa, Motoo Watanabe, Hiromitsu Nakauchi, Masatoshi Sakurai.
- Who are Celaidtx's investors?
- Celaidtx's investors include Kobe University Capital, OSAKA University Venture Capital, UTEC.






